HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.
HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.
复制标题
肺COVID-19疾病期间的HLA依赖性异质性和巨噬细胞免疫蛋白酶体激活。
DOI:
10.1186/s12967-021-02965-5
复制
发表时间:
2021-07-05
影响因子:
7.4
通讯作者:
Griscelli F
中科院分区:
文献类型:
--
作者:
Desterke C;Turhan AG;Bennaceur-Griscelli A;Griscelli F
The worldwide pandemic caused by the SARS-CoV-2 virus is characterized by significant and unpredictable heterogeneity in symptoms that remains poorly understood. Transcriptome and single cell transcriptome of COVID19 lung were integrated with deeplearning analysis of MHC class I immunopeptidome against SARS-COV2 proteome. An analysis of the transcriptomes of lung samples from COVID-19 patients revealed that activation of MHC class I antigen presentation in these tissues was correlated with the amount of SARS-CoV-2 RNA present. Similarly, a positive relationship was detected in these samples between the level of SARS-CoV-2 and the expression of a genomic cluster located in the 6p21.32 region (40 kb long, inside the MHC-II cluster) that encodes constituents of the immunoproteasome. An analysis of single-cell transcriptomes of bronchoalveolar cells highlighted the activation of the immunoproteasome in CD68 + M1 macrophages of COVID-19 patients in addition to a PSMB8-based trajectory in these cells that featured an activation of defense response during mild cases of the disease, and an impairment of alveolar clearance mechanisms during severe COVID-19. By examining the binding affinity of the SARS-CoV-2 immunopeptidome with the most common HLA-A, -B, and -C alleles worldwide, we found higher numbers of stronger presenters in type A alleles and in Asian populations, which could shed light on why this disease is now less widespread in this part of the world. HLA-dependent heterogeneity in macrophage immunoproteasome activation during lung COVID-19 disease could have implications for efforts to predict the response to HLA-dependent SARS-CoV-2 vaccines in the global population. The online version contains supplementary material available at 10.1186/s12967-021-02965-5.
登录
查看更多内容
DOI:
10.4049/jimmunol.1700893
发表时间:
2017-11-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Jurtz V;Paul S;Andreatta M;Marcatili P;Peters B;Nielsen M
通讯作者:
Nielsen M
影响因子:
5.8
作者:
Desterke C;Turhan AG;Bennaceur-Griscelli A;Griscelli F
通讯作者:
Griscelli F
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
14.9
作者:
Chen J;Bardes EE;Aronow BJ;Jegga AG
通讯作者:
Jegga AG
影响因子:
64.5
作者:
Huber, Eva M.;Basler, Michael;Groll, Michael
通讯作者:
Groll, Michael